Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hirotaka Matsuo is active.

Publication


Featured researches published by Hirotaka Matsuo.


Biochimica et Biophysica Acta | 2001

Human L-type amino acid transporter 1 (LAT1) : characterization of function and expression in tumor cell lines

Osamu Yanagida; Yoshikatsu Kanai; Arthit Chairoungdua; Do Kyung Kim; Hiroko Segawa; Tomoko Nii; Seok Ho Cha; Hirotaka Matsuo; Jun-ichi Fukushima; Yoshiki Fukasawa; Yoshiko Tani; Yutaka Taketani; Hiroshi Uchino; Ju-Young Kim; Jun Inatomi; Isao Okayasu; Ken-ichi Miyamoto; Eiji Takeda; Tomoyuki Goya; Hitoshi Endou

System L is a major nutrient transport system responsible for the transport of large neutral amino acids including several essential amino acids. We previously identified a transporter (L-type amino acid transporter 1: LAT1) subserving system L in C6 rat glioma cells and demonstrated that LAT1 requires 4F2 heavy chain (4F2hc) for its functional expression. Since its oncofetal expression was suggested in the rat liver, it has been proposed that LAT1 plays a critical role in cell growth and proliferation. In the present study, we have examined the function of human LAT1 (hLAT1) and its expression in human tissues and tumor cell lines. When expressed in Xenopus oocytes with human 4F2hc (h4F2hc), hLAT1 transports large neutral amino acids with high affinity (K(m)= approximately 15- approximately 50 microM) and L-glutamine and L-asparagine with low affinity (K(m)= approximately 1.5- approximately 2 mM). hLAT1 also transports D-amino acids such as D-leucine and D-phenylalanine. In addition, we show that hLAT1 accepts an amino acid-related anti-cancer agent melphalan. When loaded intracellularly, L-leucine and L-glutamine but not L-alanine are effluxed by extracellular substrates, confirming that hLAT1 mediates an amino acid exchange. hLAT1 mRNA is highly expressed in the human fetal liver, bone marrow, placenta, testis and brain. We have found that, while all the tumor cell lines examined express hLAT1 messages, the expression of h4F2hc is varied particularly in leukemia cell lines. In Western blot analysis, hLAT1 and h4F2hc have been confirmed to be linked to each other via a disulfide bond in T24 human bladder carcinoma cells. Finally, in in vitro translation, we show that hLAT1 is not a glycosylated protein even though an N-glycosylation site has been predicted in its extracellular loop, consistent with the property of the classical 4F2 light chain. The properties of the hLAT1/h4F2hc complex would support the roles of this transporter in providing cells with essential amino acids for cell growth and cellular responses, and in distributing amino acid-related compounds.


Biochimica et Biophysica Acta | 2001

Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells

Ju-Young Kim; Yoshikatsu Kanai; Arthit Chairoungdua; Seok Ho Cha; Hirotaka Matsuo; Do Kyung Kim; Jun Inatomi; Hiroki Sawa; Yoshiteru Ida; Hitoshi Endou

A human cDNA for amino acid transport system x(C)(-) was isolated from diethyl maleate-treated human glioma U87 cells. U87 cells expressed two variants of system x(C)(-) transporters hxCTa and hxCTb with altered C-terminus regions probably generated by the alternative splicing at 3-ends. Both hxCTa and hxCTb messages were also detected in spinal cord, brain and pancreas, although the level of hxCTb expression appears to be lower than that of hxCTa in these tissues. When expressed in Xenopus oocytes, hxCTb required the heavy chain of 4F2 cell surface antigen (4F2hc) and exhibited the Na(+)-independent transport of L-cystine and L-glutamate, consistent with the properties of system x(C)(-). In agreement with this, 137 kDa band was detected by either anti-xCT or anti-4F2hc antibodies in the non-reducing condition in western blots, whereas it shifted to 50 kDa or 90 kDa bands in the reducing condition, indicating the association of two proteins via disulfide bands. We found that the expression of xCT was rapidly induced in U87 cells upon oxidative stress by diethyl maleate treatment, which was accompanied by the increase in the L-cystine uptake by U87 cells. Because of this highly regulated nature, xCT in glial cells would fulfill the task to protect neurons against oxidative stress by providing suitable amount of cystine to produce glutathione.


Neuroscience Letters | 2000

Cloning and characterization of a human brain Na+-independent transporter for small neutral amino acids that transports d-serine with high affinity

Jun Nakauchi; Hirotaka Matsuo; Do Kyung Kim; Akiteru Goto; Arthit Chairoungdua; Seok Ho Cha; Jun Inatomi; Yoshiaki Shiokawa; Kazuyoshi Yamaguchi; Isamu Saito; Hitoshi Endou; Yoshikatsu Kanai

We isolated a cDNA for the human homologue of system asc transporter Asc-1 from human brain. The encoded protein designated as hAsc-1 (human Asc-1) exhibited 91 % sequence identity to mouse Asc-1. Consistent with mouse Asc-1, hAsc-1 required 4F2 heavy chain for its functional expression in Xenopus oocytes. hAsc-1 exhibited the properties of amino acid transport system asc which transports small neutral amino acids in a Na(+)-independent manner. hAsc-1 transported D-serine at high affinity with a K(m) value of 22.8 microM. In brain, 2.0 kb mRNA was highly expressed. hAsc-1 gene was mapped to human chromosome 19, region q12-q13.1. Because of the high-affinity transport with the K(m) value close to the physiological concentration of D-serine, together with the high levels of expression in brain, hAsc-1 is proposed to play significant roles in the D-serine mobilization in brain.


Neuroscience Letters | 2004

High affinity D- and L-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices.

Hirotaka Matsuo; Yoshikatsu Kanai; Motohide Tokunaga; Takahiro Nakata; Arthit Chairoungdua; Hisako Ishimine; Shingo Tsukada; Hidetoshi Ooigawa; Hiroshi Nawashiro; Yasushi Kobayashi; Jun Fukuda; Hitoshi Endou

System asc transporter Asc-1, expressed in the brain, transports D- and L-serine with high affinity. To determine the localization of Asc-1 in the rat brain, we isolated a cDNA for the rat orthologue of Asc-1. The encoded protein designated as rAsc-1 (rat Asc-1) exhibited 98% sequence identity to mouse Asc-1 (mAsc-1). Based on amino acid sequences of rAsc-1 and mAsc-1, two polyclonal antibodies against Asc-1 were generated and used for the immunohistochemical analysis on the cerebral and cerebellar cortices of rats and mice. Asc-1 immunoreactivity was detected in neurons, including cerebellar Purkinje neurons and pyramidal neurons in the neocortex and hippocampus. It was clearly localized in dendrites as well as somata. The localization of Asc-1 in brain suggests the significant contribution of Asc-1 to amino acid mobilization in brains including the synaptic clearance of D-serine and the neuronal uptake of L-serine that is essential for survival and dendrite growth of Purkinje neurons in particular.


Human Cell | 2002

The Role of CD98 in Astrocytic Neoplasms

Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai

The high expression of CD98 was reported in some normal tissues, including blood brain barrier, activated lymphocytes, the basal layer of skin, proximal tubles of kidney, placenta, testis and a wide variety of tumors. The CD98 complex consists of an 80–85kD heavy chain (4F2hc/FRP-1) and a 40–45kD light chain. CD98hc, 4F2hc, and FRP-1 are the same glycosylated protein each other and define antigenicity of CD98. LAT1, the sodium-independent L-type amino acid transporter 1, has been identified as a light chain of the CD98 heterodimer from C6 glioma cells. LAT1 also corresponds to TA1, an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. Increased LAT1 expression was found in various malignancies including human gliomas. Several studies implicated the important role of LAT1 and 4F2hc in malignant transformation and carcinogenesis. The LAT1-CD98 pathway may represent a unique therapeutic target for cancer intervention.


Chromosome Research | 2000

Mouse Asc-1 (asc-type amino acid transporter 1) maps to chromosome 7, region B1-B5.

Hirotaka Matsuo; Arthit Chairoungdua; Do Kyung Kim; Seok Ho Cha; J. Fukuda; Hitoshi Endou; Yoshikatsu Kanai

D-Serine is an endogenous modulator of N-methyl-D-aspartate (NMDA)/glutamate receptors [1]. A high af¢nity mammalian transporter for D-serine, expressed in brain, has recently been identi¢ed [2] (Kanai.Y; GenBank Accession AB026688), and designated as Asc-1. This transporter associates with 4F2 heavy chain [2,3], and exhibits substrate selectivity for small neutral Dand L-amino acids, including D-serine [2]. Thus, Asc-1 is proposed to play signi¢cant roles in D-serine mobilization and modulation of NMDA/glutamate receptors in brain. A full cDNA probe of mouse Asc-1 (1.7 kb) was used for £uorescence in situ hybridization as described previously [4,5]. Chromosomes were stained before analysis with propidium iodide as counterstain and DAPI for chromosome identi¢cation. The detection ef¢ciency was 60% for the probe (of 100 mitotic ¢gures checked, 60 showed hybridization signals on one pair of chromosomes). Using DAPI banding to identify the speci¢c chromosome, the assignment of signals from the probe to mouse chromosome 7, region B1-B5 was obtained.


Genomics | 2002

The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location.

Do Kyung Kim; Yoshikatsu Kanai; Hirotaka Matsuo; Ju-Young Kim; Arthit Chairoungdua; Yukari Kobayashi; Atsushi Enomoto; Seok Ho Cha; Tomoyuki Goya; Hitoshi Endou


Kidney International | 2001

Human cystinuria-related transporter : Localization and functional characterization

Ken-ichi Mizoguchi; Seok Ho Cha; Arthit Chairoungdua; Do Kyung Kim; Yasuhiro Shigeta; Hirotaka Matsuo; Jun-ichi Fukushima; Yusuke Awa; Koichiro Akakura; Tomoyuki Goya; Haruo Ito; Hitoshi Endou; Yoshikatsu Kanai


Kidney International | 2006

A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporter

Yasuhiro Shigeta; Yoshikatsu Kanai; Arthit Chairoungdua; N. Ahmed; Shinichi Sakamoto; Hirotaka Matsuo; Do Kyung Kim; Masaaki Fujimura; Naohiko Anzai; Kenichi Mizoguchi; Takeshi Ueda; Koichiro Akakura; Tomohiko Ichikawa; Haruo Ito; Hitoshi Endou


GOUT AND NUCLEIC ACID METABOLISM | 2018

ADH1B と ALDH2 の機能低下型変異は独立した痛風発症のリスクである

Makoto Kawaguchi; Hirotaka Matsuo; Masayuki Sakiyama; Seiko Shimizu; Toshihide Higashino; Akiyoshi Nakayama; Kimiyoshi Ichida; Toru Shimizu; Hiroshi Ooyama; Nariyoshi Shinomiya

Collaboration


Dive into the Hirotaka Matsuo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hisako Ishimine

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Fukuda

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Motohide Tokunaga

National Defense Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge